ABI
AMGN icon

Adamant Biomedical Investments’s Amgen AMGN Stock Holding History

Adamant Biomedical Investments’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$15.1M Sell
95,000
-5,000
-5% -$779K 3.62% 4
2014
Q3 		$14M Buy
+100,000
New +$13.1M 3.51% 4

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Adamant Biomedical Investments's AMGN Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Amgen (AMGN) stake by 5% in Q4 2014, selling an estimated $779K and leaving 95,000 shares worth $15.1M. The position accounts for 3.62% of the portfolio, ranked #4.

Adamant Biomedical Investments first reported a position in AMGN in Q3 2014 and has held it in 2 quarters since. 1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

  • Adamant Biomedical Investments held 95,000 shares of Amgen worth $15.1M as of Q4 2014.
  • Adamant Biomedical Investments sold 5,000 Amgen shares in Q4 2014, an estimated $779K.
  • Amgen made up 3.62% of Adamant Biomedical Investments's portfolio in Q4 2014, its #4 holding.
  • Adamant Biomedical Investments first reported a position in Amgen in Q3 2014 and has held it in 2 quarters since.
  • 1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.